메뉴 건너뛰기




Volumn 20, Issue 2, 2011, Pages 153-157

Antiphospholipid antibodies and the brain: A consensus report

Author keywords

antiphospholipid syndrome; stroke; thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

EID: 79953302178     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310396748     Document Type: Conference Paper
Times cited : (42)

References (43)
  • 2
    • 0142040432 scopus 로고    scopus 로고
    • Neuronal and Astrocytic Damage in Systemic Lupus Erythematosus Patients with Central Nervous System Involvement
    • DOI 10.1002/art.11279
    • Trysberg E, Nylen K, Rosengren LE, et al. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003; 48: 2881-2887. (Pubitemid 37280617)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.10 , pp. 2881-2887
    • Trysberg, E.1    Nylen, K.2    Rosengren, L.E.3    Tarkowski, A.4
  • 3
    • 0032908439 scopus 로고    scopus 로고
    • Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes
    • Chapman J, Cohen-Armon M, Shoenfeld Y, et al. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127-133. (Pubitemid 29103599)
    • (1999) Lupus , vol.8 , Issue.2 , pp. 127-133
    • Chapman, J.1    Cohen-Armon, M.2    Shoenfeld, Y.3    Korczyn, A.D.4
  • 5
    • 60849110567 scopus 로고    scopus 로고
    • Antiphospholipid antibodies: Paradigm in transition
    • Horstman LL, Jy W, Bidot CJ, et al. Antiphospholipid antibodies: paradigm in transition. J Neuroinflammation 2009; 6: 3.
    • (2009) J Neuroinflammation , vol.6 , pp. 3
    • Horstman, L.L.1    Jy, W.2    Bidot, C.J.3
  • 6
    • 70449729881 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: A case-control study
    • Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
    • (2009) Lancet Neurol , vol.8 , pp. 998-1005
    • Urbanus, R.T.1    Siegerink, B.2    Roest, M.3
  • 7
    • 0027989330 scopus 로고
    • The anticardiolipin antibody in elderly stroke patients: Its effects on stroke types, recurrence, and the coagulation-fibrinolysis system
    • Tohgi H, Takahashi H, Kasiwaya M, Watanabe K, Hayama K. The anticardiolipin antibody in elderly Stroke patients: its effects on stroke types, recurrence and the coagulation-fibrinolysis system. Acta Neurol Scand 1994; 90: 86-90. (Pubitemid 24261202)
    • (1994) Acta Neurologica Scandinavica , vol.90 , Issue.2 , pp. 86-90
    • Tohgi, H.1    Takahashi, H.2    Kashiwaya, M.3    Watanabe, K.4    Hayama, K.5
  • 8
    • 0029031918 scopus 로고
    • Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome
    • Levine SR, Brey RL, Sawaya KL, et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995; 38: 119-124.
    • (1995) Ann Neurol , vol.38 , pp. 119-124
    • Levine, S.R.1    Brey, R.L.2    Sawaya, K.L.3
  • 9
    • 0343567810 scopus 로고    scopus 로고
    • Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death
    • APASS
    • APASS. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. Neurology 1997; 48: 91-94.
    • (1997) Neurology , vol.48 , pp. 91-94
  • 11
    • 0035009690 scopus 로고    scopus 로고
    • Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: A prospective study
    • DOI 10.1007/s004150170176
    • Heinzlef O, Abuaf N, Cohen A, Amarenco P French Study of Aortic Plaques in Stroke Group. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study. J Neurology 2001; 248: 373-379. (Pubitemid 32477327)
    • (2001) Journal of Neurology , vol.248 , Issue.5 , pp. 373-379
    • Heinzlef, O.1    Abuaf, N.2    Cohen, A.3    Amarenco, P.4
  • 12
    • 0036126596 scopus 로고    scopus 로고
    • Anticardiolipin antibodies and mortality in patients with ischemic stroke: A prospective follow-up study
    • DOI 10.1159/000048623
    • Tanne D, D'Olhaberriague L, Trivedi AM, Salowich-Palm L, Schyltz LR, Levine SR. Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Neuroepidemiology 2002; 21: 93-99. (Pubitemid 34233893)
    • (2002) Neuroepidemiology , vol.21 , Issue.2 , pp. 93-99
    • Tanne, D.1    D'Olhaberriague, L.2    Trivedi, A.M.3    Salowich-Palm, L.4    Schultz, L.R.5    Levine, S.R.6
  • 13
    • 10744223871 scopus 로고    scopus 로고
    • Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients with Ischemic Stroke
    • DOI 10.1001/jama.291.5.576
    • Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-584. (Pubitemid 38500311)
    • (2004) Journal of the American Medical Association , vol.291 , Issue.5 , pp. 576-584
    • Levine, S.R.1
  • 14
    • 33750122025 scopus 로고    scopus 로고
    • Anticardiolipin antibodies, recurrent stroke and vascular events: A prospective study on 210 patients
    • Tanasescu R, Ticmeanu M, Nicolau A, et al. Anticardiolipin antibodies, recurrent stroke and vascular events: a prospective study on 210 patients. Rom J Inter Med 2005; 43: 79-88.
    • (2005) Rom J Inter Med , vol.43 , pp. 79-88
    • Tanasescu, R.1    Ticmeanu, M.2    Nicolau, A.3
  • 15
    • 58149149373 scopus 로고    scopus 로고
    • Pediatric antiphospholipid syndrome: Clinical and immunologic features of 121 patients in an international registry
    • Avcin T, Cimaz R, Silverman ED, et al. Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. Pediatrics 2008; 122: e1100-e1107.
    • (2008) Pediatrics , vol.122
    • Avcin, T.1    Cimaz, R.2    Silverman, E.D.3
  • 16
    • 39449121252 scopus 로고    scopus 로고
    • A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus
    • DOI 10.1002/art.23334
    • Avcin T, Benseler SM, Tyrrell PN, et al. A follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 2008; 59: 206-213. (Pubitemid 351272956)
    • (2008) Arthritis Care and Research , vol.59 , Issue.2 , pp. 206-213
    • Avcin, T.1    Benseler, S.M.2    Tyrrell, P.N.3    Cucnik, S.4    Silverman, E.D.5
  • 17
    • 0027936392 scopus 로고
    • High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia
    • Angelini L, Ravelli A, Caporali R, et al. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94: 500-503. (Pubitemid 24295030)
    • (1994) Pediatrics , vol.94 , Issue.4 I , pp. 500-503
    • Angelini, L.1    Ravelli, A.2    Caporali, R.3    Rumi, V.4    Nardocci, N.5    Martini, A.6
  • 19
    • 33846621547 scopus 로고    scopus 로고
    • Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus
    • DOI 10.1161/01.STR.0000254476.05620.14, PII 0000767020070200000028
    • Mikdashi J, Handwerger B, Langenberg P, Miller M, Kittner S. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 2007; 38: 281-285. (Pubitemid 46184295)
    • (2007) Stroke , vol.38 , Issue.2 , pp. 281-285
    • Mikdashi, J.1    Handwerger, B.2    Langenberg, P.3    Miller, M.4    Kittner, S.5
  • 20
    • 10444248119 scopus 로고    scopus 로고
    • Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events
    • Toloza SM, Uribe AG, McGwin Jr G, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947-3957.
    • (2004) Arthritis Rheum , vol.50 , pp. 3947-3957
    • Toloza, S.M.1    Uribe, A.G.2    McGwin Jr., G.3
  • 21
    • 25644443865 scopus 로고    scopus 로고
    • Risk factors for recurrent thrombosis: Prospective study of a cohort of Japanese systemic lupus erythematosus
    • DOI 10.1177/000331970505600512
    • Akimoto T, Kobayashi S, Tamura N, et al. Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus. Angiology 2005; 56: 601-609. (Pubitemid 41383314)
    • (2005) Angiology , vol.56 , Issue.5 , pp. 601-609
    • Akimoto, T.1    Kobayashi, S.2    Tamura, N.3    Ohsawa, T.4    Kawano, T.5    Tanaka, M.6    Hashimoto, H.7
  • 22
    • 0032908586 scopus 로고    scopus 로고
    • A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus
    • DOI 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O
    • Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 728-734. (Pubitemid 29171993)
    • (1999) Arthritis and Rheumatism , vol.42 , Issue.4 , pp. 728-734
    • Hanly, J.G.1    Hong, C.2    Smith, S.3    Fisk, J.D.4
  • 23
    • 0032913451 scopus 로고    scopus 로고
    • A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus
    • DOI 10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L
    • Menon S, Jameson-Shortall E, Newman Hall-Craggs SP, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 735-741. (Pubitemid 29171994)
    • (1999) Arthritis and Rheumatism , vol.42 , Issue.4 , pp. 735-741
    • Menon, S.1    Jameson-Shortall, E.2    Newman, S.P.3    Hall-Craggs, M.R.4    Chinn, R.5    Isenberg, D.A.6
  • 24
    • 12544253380 scopus 로고    scopus 로고
    • Predictors of cognitive dysfunction in patients with systemic lupus erythematosus
    • McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 2005; 64: 297-303.
    • (2005) Neurology , vol.64 , pp. 297-303
    • McLaurin, E.Y.1    Holliday, S.L.2    Williams, P.3    Brey, R.L.4
  • 25
    • 37349066221 scopus 로고    scopus 로고
    • General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus
    • Tomietto P, Annese V, D'agostini S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007; 57: 1461-1472.
    • (2007) Arthritis Rheum , vol.57 , pp. 1461-1472
    • Tomietto, P.1    Annese, V.2    D'Agostini, S.3
  • 26
    • 45049088504 scopus 로고    scopus 로고
    • Primary antiphospholipid syndrome in Latin American mestizo patients: Clinical and immunologic characteristics and comparison with European patients
    • Mejia-Romero R, Garcia-Carrasco M, Galarza-Maldonado C, et al. Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients. Clin Rheumatol 2008; 27: 891-897.
    • (2008) Clin Rheumatol , vol.27 , pp. 891-897
    • Mejia-Romero, R.1    Garcia-Carrasco, M.2    Galarza-Maldonado, C.3
  • 28
    • 0035092781 scopus 로고    scopus 로고
    • Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis
    • DOI 10.1002/ana.81
    • Sastre-Garriga J, Reverter JC, Font J, et al. Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis. Ann Neurol 2001; 49: 408-411. (Pubitemid 32202798)
    • (2001) Annals of Neurology , vol.49 , Issue.3 , pp. 408-411
    • Sastre-Garriga, J.1    Reverter, J.C.2    Font, J.3    Tintore, M.4    Espinosa, G.5    Montalban, X.6
  • 29
    • 0033850322 scopus 로고    scopus 로고
    • Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: A study of 89 patients
    • Roussel V, Yi F, Jauberteau MO, et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: a study of 89 patients. J Autoimmun 2000; 14: 259-265.
    • (2000) J Autoimmun , vol.14 , pp. 259-265
    • Roussel, V.1    Yi, F.2    Jauberteau, M.O.3
  • 30
    • 38849123295 scopus 로고    scopus 로고
    • Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: A preliminary study
    • Bidot CJ, Horstman LL, Jimenez JJ, et al. Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study. BMC Neurol 2007; 7: 36.
    • (2007) BMC Neurol , vol.7 , pp. 36
    • Bidot, C.J.1    Horstman, L.L.2    Jimenez, J.J.3
  • 31
    • 0033984834 scopus 로고    scopus 로고
    • Can neurologic manifestations of hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature
    • DOI 10.1097/00005792-200001000-00006
    • Cuadrado MJ, Khamashta MA, Ballesteros A, et al. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000; 79: 57-68. (Pubitemid 30077737)
    • (2000) Medicine , vol.79 , Issue.1 , pp. 57-68
    • Cuadrado, M.J.1    Khamashta, M.A.2    Ballesteros, A.3    Godfrey, T.4    Simon, M.J.5    Hughes, G.R.V.6
  • 32
    • 0032940259 scopus 로고    scopus 로고
    • Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS?
    • Ijdo JW, Conti-Kelly AM, Greco P, et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illness: MS or APS? Lupus 1999; 8: 109-115.
    • (1999) Lupus , vol.8 , pp. 109-115
    • Ijdo, J.W.1    Conti-Kelly, A.M.2    Greco, P.3
  • 33
    • 0031754511 scopus 로고    scopus 로고
    • A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?
    • Karussis D, Leker RR, Ashkenazi A, et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 1998; 44: 629-634.
    • (1998) Ann Neurol , vol.44 , pp. 629-634
    • Karussis, D.1    Leker, R.R.2    Ashkenazi, A.3
  • 35
    • 0028354654 scopus 로고
    • Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
    • Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 586-571.
    • (1994) Arthritis Rheum , vol.37 , pp. 586-1571
    • Herranz, M.T.1    Rivier, G.2    Khamashta, M.A.3    Blaser, K.U.4    Hughes, G.R.V.5
  • 36
    • 0029815233 scopus 로고    scopus 로고
    • Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients
    • Liou HH, Wang CR, Chen CJ, et al. Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus 1996; 5: 307-312.
    • (1996) Lupus , vol.5 , pp. 307-312
    • Liou, H.H.1    Wang, C.R.2    Chen, C.J.3
  • 37
    • 0035019921 scopus 로고    scopus 로고
    • 2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: Association with the presence of seizures
    • DOI 10.1191/096120301671577528
    • Shrivastava A, Dwivedi S, Aggarwal A, Misra R. Anti-cardiolipin and anti-beta2 glycoprotein 1 antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus 2001; 10: 45-50. (Pubitemid 32416688)
    • (2001) Lupus , vol.10 , Issue.1 , pp. 45-50
    • Shrivastava, A.1    Dwivedi, S.2    Aggarwal, A.3    Misra, R.4
  • 38
    • 8844244629 scopus 로고    scopus 로고
    • Epileptic seizures in systemic lupus erythematosus
    • Appenzeller S, Cendes F, Costallat LTL. Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808-1812. (Pubitemid 39532373)
    • (2004) Neurology , vol.63 , Issue.10 , pp. 1808-1812
    • Appenzeller, S.1    Cendes, F.2    Costallat, L.T.L.3
  • 39
    • 0029003563 scopus 로고
    • Significance of antibodies to cardiolipin in selected patients with systemic lupus erythematosus: Clinical and laboratory associations
    • The SLE Study Group
    • Sachse C, Luthke K, Hartung K, et al. Significance of antibodies to cardiolipin in selected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group. Rheumatol Int 1995; 15: 23-29.
    • (1995) Rheumatol Int , vol.15 , pp. 23-29
    • Sachse, C.1    Luthke, K.2    Hartung, K.3
  • 40
    • 0030624994 scopus 로고    scopus 로고
    • Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients
    • Formiga F, Mitjavila F, Pac M, Moga I. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients. Lupus 1997; 6: 486.
    • (1997) Lupus , vol.6 , pp. 486
    • Formiga, F.1    Mitjavila, F.2    Pac, M.3    Moga, I.4
  • 42
    • 79953307645 scopus 로고    scopus 로고
    • Antiphospholipid and antinuclear antibodies in patients with epilepsy or new onset seizure disorders
    • Peltola JT, Haapala A, Isojarvi JI, et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new onset seizure disorders. Am J Med 2000; 103: 33-37.
    • (2000) Am J Med , vol.103 , pp. 33-37
    • Peltola, J.T.1    Haapala, A.2    Isojarvi, J.I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.